Literature review · Skin & hair

Snap8 / acetyl octapeptide-3

The checked human evidence concerns multi-ingredient microneedle patches. It does not isolate acetyl octapeptide-3 or establish an effect of catalogue vials or nasal sprays.

By HeartPep · Reviewed · 2 selected source records

Buy from HeartPep.com

Laboratory research only. Not for human or veterinary use.

At a glance

Two formulation studies provide human skin-measurement data. Each changes several ingredients and a delivery system together, preventing attribution to one peptide.

Identity & scope

SNAP-8 is associated with acetyl octapeptide-3 in the identity record used by the existing catalogue references. A supplier name alone is not analytical confirmation of material identity.

Catalogue labels covered: Snap8.

What the research shows

  • The 2024 patch comparison reported improvements in selected wrinkle and skin measurements versus a hyaluronic-acid-only patch.
  • An earlier single-centre study reported changes after a multi-active patch regimen.

Critical interpretation

The comparator determines what can be attributed

The 2024 experiment compares a formulation containing several actives with a hyaluronic-acid patch. It can test the package of ingredients and device together, but it has no arm removing only acetyl octapeptide-3. Attribution to that peptide or a claimed interaction therefore remains a hypothesis. The earlier multi-active study has the same ingredient-attribution problem. Two positive formulation reports do not become two independent demonstrations of isolated-peptide efficacy. [1] [2]

A delivery device is part of the tested intervention

A dissolving microneedle is designed to alter delivery through the skin barrier. Its results cannot establish what reaches tissue from a plain solution, conventional cosmetic, vial or nasal preparation. Instrumental skin measurements and short tolerability observation also answer narrower questions than lasting cosmetic benefit or long-term safety. Further research would need ingredient-specific comparisons, independently characterised formulations and follow-up beyond the short observation periods before a broad peptide claim could be justified. [1] [2]

Read participant flow alongside the headline

The later paper enrolled 24 people and analysed 21 completers. That is a small observation window with some attrition, not a broad assurance about everyone who might encounter the ingredient. A useful replication would preserve participant flow, prespecified endpoints and ingredient-specific comparisons alongside its headline result. [1]

Limitations & uncertainties

  • Neither study isolates this ingredient's contribution, and the earlier study's abstract does not establish a randomised ingredient-specific comparison.
  • Short-term cosmetic measurements cannot establish systemic safety, nasal bioavailability or comparable effects of another formulation.

Open research questions

  • Would an independently run trial isolate the peptide's effect from the other ingredients and delivery device?

Selected papers & source records

Download bibliography
Human studyComponent evidenceFull text consulted

1. Clinical Safety and Efficacy Evaluation of a Dissolving Microneedle Patch Having Dual Anti-Wrinkle Effects With Safe and Long-Term Activities (opens in a new tab)

Shin JY, Han D, Yoon KY, Jeong DH, Park YI (2024). Annals of Dermatology. DOI: 10.5021/ad.23.136 (opens in a new tab) · PMID 39082657

Design & population
Opposite-eye comparison of combination versus hyaluronic-acid-only microneedle patches over 28 days; 24 adults enrolled and 21 completed.
What the study found
Several skin and wrinkle endpoints favoured the combination; no adverse effects were reported during the short study.
Limits on interpretation
Multiple active ingredients, small sample and device-specific delivery. Several authors were affiliated with the patch company.
Human studyComponent evidenceAbstract / record checked

2. Efficacy of bioactive peptides loaded on hyaluronic acid microneedle patches: A monocentric clinical study (opens in a new tab)

Avcil M, Akman G, Klokkers J, Jeong D, Çelik A (2020). Journal of Cosmetic Dermatology. DOI: 10.1111/jocd.13009 (opens in a new tab) · PMID 31134751

Design & population
Twelve-week single-centre study of a patch containing several peptides, adenosine and seaweed extracts.
What the study found
Authors reported improved wrinkle, hydration, density and thickness measurements and no reported skin reactions.
Limits on interpretation
A formulation result, not proof of isolated acetyl octapeptide-3 efficacy. Manufacturer-funded, with commercial affiliations.

Search & review scope

Targeted searches of the catalogue's primary reference and related acetyl-octapeptide microneedle studies.. Checked 9 November 2026.

Two human multi-ingredient formulation reports. Full-text 2024 methods, participant flow, results and discussion were checked at the journal; the earlier report remains abstract-reviewed.

Not a complete ingredient dossier or systematic search. Ingredient-containing trials do not validate supplier material; a comprehensive publication-status audit was not performed.

Recorded search terms
  • 39082657 acetyl octapeptide microneedle
  • Acetyl Octapeptide 31134751 authors
  • Clinical Safety and Efficacy Evaluation Microneedle retracted
  • Clinical Safety and Efficacy Evaluation 21 subjects Shin
  • Clinical Safety and Efficacy Evaluation random 24 microneedle

Read the collection’s methods and editorial limits. For formal research, assess and cite the original paper.

Cite this review

HeartPep. Snap8 / acetyl octapeptide-3: literature review. HeartPep literature library. Reviewed 9 November 2026. https://heartpep.com/us/research/library/snap8.

HeartPep is the commercial publisher of this secondary summary. It is not a peer-reviewed primary paper. Cite the original studies for their findings.

Buy from HeartPep.com

Laboratory research only. Not for human or veterinary use.

← All reviews and reference notes